鄭陽，王曉明

磁化傳遞成像和酰胺質(zhì)子轉(zhuǎn)移成像聯(lián)合評價新生兒腦損傷的初步研究

鄭陽，王曉明*

目的應(yīng)用酰胺質(zhì)子轉(zhuǎn)移成像(amide proton transfer，APT)聯(lián)合磁化傳遞(magnetization transfer，MT)成像對新生兒從腦內(nèi)環(huán)境角度評估新生兒腦損傷。材料與方法新生兒共38名，腦損傷13例，為病例組；常規(guī)MRI檢查腦內(nèi)無異常25例為對照組。常規(guī)MRI檢查后補充APT-MT成像掃描。測量所有新生兒雙側(cè)額葉深部白質(zhì)、基底節(jié)區(qū)、枕葉深部白質(zhì)的APT值以及磁化傳遞率(magnetization transfer ratio，MTR)值（以下用APT/MTR表示），以及病例組病灶區(qū)及其對側(cè)的APT/MTR值。采用SPSS 19.0軟件進行統(tǒng)計分析。結(jié)果(1)對照組中，額葉深部白質(zhì)、基底節(jié)及枕葉深部白質(zhì)APT/MTR值均有顯著性差異(P＜0.05)。(2)對照組中，APT/MTR值隨孕齡增長而逐漸升高。(3)病例組病灶內(nèi)APT/ MTR值低于對側(cè)(P＜0.05)。結(jié)論圍產(chǎn)期缺氧缺血是全腦代謝變化，APT-MT成像可從內(nèi)環(huán)境及分子水平評估新生兒腦損傷。

磁共振成像；新生兒；腦；酰胺質(zhì)子轉(zhuǎn)移成像；磁化傳遞成像

Key wordsMagnetic resonance imaging; Neonatal; Brain; Amide proton transfer; Magnetization transfer imaging

缺氧缺血腦損傷是圍產(chǎn)期多種原因引起的腦組織病變，是一種全腦的缺氧缺血(hypoxic ischemic，HI)后再灌注性腦損傷。目前再灌注損傷在HIE發(fā)病中的作用日益受到重視，當(dāng)腦組織由低灌注轉(zhuǎn)移到再灌注時，會出現(xiàn)一系列病理生理改變。當(dāng)腦內(nèi)HI時，有氧能量代謝過程障礙[1-3]，有氧代謝轉(zhuǎn)為無氧代謝，無氧代謝過程產(chǎn)生乳酸，腦組織內(nèi)乳酸增多，堆積的乳酸可以使糖代謝受到抑制，使ATP耗竭，從而使細胞內(nèi)酸中毒加重[4-5]。

新生兒圍產(chǎn)期各種原因造成的腦損傷，會引起腦組織內(nèi)環(huán)境的改變。有研究表明，HI后腦組織酸中毒，哺乳動物腦組織細胞內(nèi)pH值約在7.2～7.3左右，細胞外pH值約在7.3～7.4左右[6-8]。腦內(nèi)pH的調(diào)節(jié)至關(guān)重要，對于腦內(nèi)蛋白質(zhì)的結(jié)構(gòu)及酶的作用尤為明顯，因此及時了解及調(diào)控細胞內(nèi)pH值對腦組織改善是非常重要的。能否應(yīng)用磁共振技術(shù)反映這種腦組織內(nèi)環(huán)境的變化是一個新的課題，近年來一種新的磁共振內(nèi)對比技術(shù)即酰胺質(zhì)子轉(zhuǎn)移(amide proton transfer，APT)成像[9]，可以通過水的信號變化來反映蛋白質(zhì)及體內(nèi)酸堿度的變化。APT成像信號取決于酰胺質(zhì)子和自由水質(zhì)子的交換速率[10]，而這種交換速率依賴于體內(nèi)的酸堿度及蛋白質(zhì)濃度[11-13]。APT技術(shù)正是基于上述原理利用水的信號產(chǎn)生內(nèi)對比。目前，該技術(shù)已經(jīng)在多方面進行應(yīng)用研究[14-19]。

磁化傳遞(magnetization transfer，MT)成像是通過測量生物組織內(nèi)大分子中的質(zhì)子和自由水質(zhì)子的相互作用來實現(xiàn)的[20]，大分子中的質(zhì)子包括與蛋白質(zhì)、其他大分子、膜結(jié)合的質(zhì)子。不同組織的磁化傳遞量是不同的，對組織的磁化傳遞進行定量分析，可以了解組織的特征，最常用的定量指標(biāo)是磁化傳遞率(magnetization transfer ratio，MTR)，MTR代表生物大分子完全或部分飽和所導(dǎo)致的信號百分比。本研究通過APT聯(lián)合MT成像對新生兒腦損傷進行評估，從腦內(nèi)環(huán)境角度評估新生兒腦損傷的病理生理變化。

1 材料與方法

1.1 研究對象及分組

以本院新生兒病房申請MR掃描者為研究對象，患者住院原因主要有呼吸道感染、腹瀉、發(fā)熱、皮膚黃染等，臨床醫(yī)師懷疑腦部有病變者，申請MRI檢查。排除腦內(nèi)占位，發(fā)育遲緩，先天畸形以及腦內(nèi)代謝疾病等，其中常規(guī)MRI發(fā)現(xiàn)不同程度腦白質(zhì)損傷和(或)腦梗死，作為病例組；與病例組孕齡相匹配(校正孕齡天數(shù)相差±2 d)，且常規(guī)MRI未發(fā)現(xiàn)神經(jīng)系統(tǒng)異常者，作為對照組。以上診斷均由2名及以上有經(jīng)驗的影像醫(yī)師共同完成。以上研究設(shè)計獲得本院倫理委員會批準(zhǔn)(倫理編號：2016PS280K)。在獲得患兒監(jiān)護人知情同意并經(jīng)過臨床醫(yī)生對新生兒狀態(tài)評估得到允許的前提下，完成常規(guī)MRI檢查后立即行APT-MT 成像掃描。所有新生兒在常規(guī)檢查前 30 min給予5 %的水合氯醛(50 mg/kg)灌腸，檢查時注意保暖及舒適。

1.2 常規(guī)MR掃描設(shè)備及參數(shù)

所有新生兒采用Philips 3.0 T MR儀(Achieva 3.0 T TX；Philips Healthcare Systems，Best，the Netherlands)進行掃描，筆形束，二階勻場。體線圈發(fā)射，八通道頭線圈(SENSE)接收。常規(guī)MR掃描方案：T1WI、T2WI、DWI。常規(guī)MRI序列參數(shù)如下：T1WI采用FFE序列：TR 200 ms，TE 2.3 ms，F(xiàn)OV 188 mm×155 mm，矩陣256×180，層厚5 mm，掃描時間36.8 s ；T2WI采用TSE序列：TR 200 ms，TE 4.6 ms，F(xiàn)OV 180 mm×161 mm，矩陣224×162，層厚5 mm，掃描時間42.8 s。

1.3 APT-MT序列及圖像后處理

APT-MT序列：APT-MT掃描一次采集，后處理過程中分別得出APT及MT的圖像及數(shù)據(jù)。所有新生兒采用橫斷位T1WI定位，定位于基底節(jié)層面。病例組增加顯示病灶最大層面。 APT-MT采用多次偏置射頻脈沖采集方法[21]，連續(xù)頻率飽和脈沖500 ms。APT-MT圖像采集和Z譜采集相結(jié)合同時采集。在距離水的共振頻率不同位置處(0，±0.25，±0.5，±0.75，±1，±1.5，±2，±2.5，±3 (2)，±3.25(4)，±3.5 (8)，±3.75 (4)，±4 (2)，±4.5，±5，±6 ppm和15.6 ppm；括號里的數(shù)字代表采集的次數(shù)，沒有括號標(biāo)記的表示采集一次(采集多個頻率飽和射頻脈沖，未施加射頻激勵的圖像作為標(biāo)準(zhǔn)化圖像。這種采集方法能夠校正B0場的不均勻性，得出的APT圖像有較好的信噪比，并且使掃描時間能夠更加接近于臨床應(yīng)用，單層掃描時間4 min16 s。APT-MT掃描參數(shù)如下：TR 4000 ms；TE 8.1 ms；矩陣108×71，F(xiàn)OV 170 mm×145 mm，層厚5 mm。將 APT-MT 原始數(shù)據(jù)導(dǎo)入交互式數(shù)據(jù)分析語言中的程序(IDL；Research Systems，Inc.，Boulder，CO，USA)進行分析測值并重建出偽彩圖。首先，獲得基于體素的Z譜(標(biāo)準(zhǔn)化的信號強度，Ssat/S0是31個偏置脈沖的函數(shù)，Ssat是施加飽和脈沖后的信號強度，S0是未施加飽和脈沖的信號強度)。通過一個12階的多項式擬合，獲得Z譜最低點的位置，得到B0場的不均勻分布，從而對Z譜進行場校正。在經(jīng)過校正后的Z譜取左右對稱的±3.5 ppm (APT)及15.6 ppm (MT)數(shù)據(jù)點，進行非均勻性分析[MTRasym(3.5 ppm)=Ssat(－3.5 ppm)/S0－Ssat(3.5 ppm)/ S0]、MTR=1－Ssat/S0最終獲得APT及MT權(quán)重磁共振成像，APT及MTR值用百分比表示。

1.4 感興趣區(qū)的選擇及數(shù)據(jù)后處理

感興趣區(qū)(region of interest，ROI)的選擇由有經(jīng)驗的影像醫(yī)師來完成，所有新生兒選擇雙側(cè)額葉深部白質(zhì)、基底節(jié)及枕葉深部白質(zhì)(圖1)，病例組增加病灶及病灶對側(cè)相同部位的ROI。以T1WI作為參考，小心地在APT及MT偽彩圖中勾畫并測量APT/MTR值。APT-MT偽彩圖中信號由高到低顯示為由紅～藍，相應(yīng)APT/MTR值為由大到小。ROI選擇注意避開顱骨、腦脊液及腦室。病例組ROI選擇應(yīng)在病變范圍內(nèi)，不超過病變邊緣。

1.5 統(tǒng)計學(xué)分析

數(shù)據(jù)統(tǒng)計學(xué)處理采用軟件SPSS 19.0軟件處理，計量資料以均數(shù)±標(biāo)準(zhǔn)差表示。采用配對樣本t檢驗，分析對照組各部位雙側(cè)APT/MTR值是否存在差異，若無差異，雙側(cè)APT/MTR值按部位納入各組進行分析；采用ANOVA分析，比較對照組額葉、基底節(jié)及枕葉深部白質(zhì)之間APT-MT值是否存在顯著性差異。采用兩樣本t檢驗分析病例組病灶及對側(cè)APT-MT值是否存在差異。P＜0.05為差異有統(tǒng)計學(xué)意義。

圖2 對照組新生兒腦內(nèi)APT/MTR值隨孕齡(周)的變化。A～C：為對照組腦內(nèi)額葉深部白質(zhì)、基底節(jié)及枕葉深部白質(zhì)APT值隨孕齡變化趨勢；D～F：為對照組腦內(nèi)額葉深部白質(zhì)、基底節(jié)及枕葉深部白質(zhì)MTR值隨孕齡變化趨勢。腦內(nèi)不同部位APT/MTR值隨孕齡增長而升高Fig. 2 Changes between gestational age (weeks) and APT/MTR values of control group. Changes between gestational age (weeks) and APT values in the deep white matter of the frontal lobe (A), basal ganglia (B), and deep white matter of the occipital lobe (C). Changes between gestational age (weeks) and MTR values in the deep white matter of the frontal lobe (D), basal ganglia (E), and deep white matter of the occipital lobe (F).

2 結(jié)果

2.1 研究對象

常規(guī)MRI發(fā)現(xiàn)腦損傷者(新生兒腦白質(zhì)不同程度損傷9例，左腦半球新發(fā)大面積腦梗死1例，局灶腦梗死3例)共13例，作為病例組。孕齡27～41周，中位年齡為34周+5 d。其中早產(chǎn)兒8例，中位年齡32周+1 d；足月兒5例，中位年齡37周+4 d。

與病例組孕齡匹配(校正孕齡相差≤2 d)，且常規(guī)MRI腦內(nèi)無異常表現(xiàn)新生兒25名(不包括出生窒息，先天畸形，發(fā)育落后等神經(jīng)系統(tǒng)疾病)作為對照組，孕齡27～41周，中位年齡為36周+1 d。其中包括早產(chǎn)兒13例，中位年齡為32周+3 d；足月兒12例，中位年齡為37周+5 d。

2.2 對照組新生兒APT/MTR值統(tǒng)計及分析

對照組中，各部位(額葉深部白質(zhì)、基底節(jié)及枕葉深部白質(zhì)) APT/MTR值雙側(cè)均無顯著性差異(P＞0.05)。因此，各部位雙側(cè)APT/MTR值分別納入各部位統(tǒng)計。額葉深部白質(zhì)、基底節(jié)及枕葉深部白質(zhì)之間APT/MTR值存在顯著性差異(P＜0.05)，由大到小依次為：基底節(jié)，枕葉深部白質(zhì)，額葉深部白質(zhì)。對照組新生兒各部位(雙側(cè)額葉深部白質(zhì)、基底節(jié)及枕葉深部白質(zhì)) APT/MTR值隨孕齡(周)增加呈升高趨勢(圖2，3)。

圖3 對照組不同修正月齡的新生兒腦MR軸面圖像。a～c列為早產(chǎn)兒腦(修正孕齡28周+1 d、30周+2 d、35周+5)，d列為足月兒腦(40周+3 d)。第一排為T1WI，第二排為相應(yīng)的T2WI，第三排為APT圖像，第四排為MT圖像。由圖3可見，隨著修正孕齡增長與髓鞘化形成，APT信號逐漸升高(受限于對比度)，MT成像信號也增高(基底節(jié)顯示最為明顯)Fig. 3 Axial MRI Images of neonatal brain at different corrected gestational ages. Columns a—d represent images from neonates with corrected gestational ages of 28 w+1 d、30 w+2 d、35 w+ 5, and 40 w+3 d, respectively. Images from the 4 rows are as follows: row 1=T1WI; row 2=T2WI images; row 3=APT images; and row 4 = MTR images. From Figure 3, we can conclude that with increased growth associated with age, the APT signal appears to gradually increase (signal is somewhat limited by image contrast). The MT signal is increased with gestational ages.

2.3 病例組APT/MTR值統(tǒng)計及比較

病例組13名腦損傷新生兒，病灶側(cè)APT/ MTR值與對側(cè)相對正常區(qū)域進行比較，結(jié)果顯示，病灶側(cè)APT/ MTR值與對側(cè)存在顯著差異(P＜0.05)：病灶A(yù)PT=0.45%±0.15%，病灶對側(cè)APT=0.95%±病灶MTR=12.68%± 2.03%，病灶對MTR= 17.52%±2.12%(圖4)。病變區(qū)APT/MTR信號較對側(cè)減低(圖5)。

4 討論

新生兒腦正常狀態(tài)下內(nèi)環(huán)境的成分及理化性質(zhì)在一定范圍內(nèi)保持穩(wěn)態(tài)，穩(wěn)態(tài)的維持對于腦細胞的生存及腦發(fā)育十分重要[6]。若發(fā)育過程中某種原因?qū)е麓x障礙或供能不足，腦組織缺氧導(dǎo)致局部乳酸等代謝物堆積，腦內(nèi)環(huán)境也將改變[22]。腦內(nèi)MTR值的高低主要與組織中的大分子(腦內(nèi)主要為髓鞘內(nèi)的膽固醇、脂類)的含量有關(guān)[23]，通過 MTR可以間接得到組織的內(nèi)部組成，提供組織特征。早產(chǎn)兒與足月兒腦發(fā)育程度不同，腦內(nèi)蛋白含量及髓鞘化程度不同。APT值與蛋白質(zhì)濃度及pH值均呈正相關(guān)，APT-MT值越大表示蛋白質(zhì)含量及半固態(tài)大分子含量的增加。APT是建立在MT技術(shù)基礎(chǔ)之上的，基于蛋白質(zhì)及多肽中的酰胺質(zhì)子與水質(zhì)子之間的交換，反映游離的蛋白質(zhì)氨基質(zhì)子濃度的變化。由于APT技術(shù)對組織內(nèi)酸堿度敏感[24]，在急性HI時，假定酰胺質(zhì)子濃度和溫度保持在恒定，APT值的變化主要反映pH的變化。

圖4 病灶側(cè)與病灶對側(cè)APT/MTR值分布及比較。病灶內(nèi)APT/MTR值明顯低于病灶對側(cè)Fig. 4 Distribution and comparison of lesion and contralateral region APT/MTR values. The APT/MTR values within lesion are lower than that of contralateral region.

圖5 病例組新生兒腦MR軸面圖像。a、b、c分別是T1WI、T2WI及DWI序列，d、e分別為APT及MT偽彩圖。第1行：女，38周新生兒。左腦半球新發(fā)大面積腦梗死；左腦半球呈大片長T1、長T2信號；DWI呈高信號，累及左顳、枕部及胼胝體壓部；圖d、e顯示位于左腦半球的梗死病灶較右側(cè)顯示為低信號(黑色箭頭所示，由于APT圖像分辨率有限，病灶顯示不如MT圖像明顯)。病灶及病灶對側(cè)APT/MTR值分別為：APT：0.48%，1.50%；MTR：12.86%，18.43%。第2行：女，足月。左顳葉近期新發(fā)梗死；左顳葉DWI序列呈高信號，APT及MTR偽彩圖中顯示病灶(黑色箭頭所示)信號減低。病灶及病灶對側(cè)APT/MTR值分別為：APT：0.44%，0.93%；MTR：13.43%，16.76%。第3行：男，36周+5 d。右顳葉軟化灶形成；右顳葉病灶DWI序列顯示為低信號，d、e顯示病灶(黑色箭所示)信號減低(由于軟化灶形成，腦組織部分蛋白水解，病灶處水含量增多，APT圖像中病灶中出現(xiàn)較多偽影)。病灶及病灶對側(cè)APT/MTR值分別為：APT：0.29%，0.91%；MTR：10.25%，16.31%Fig. 5 Axial MRI Images of neonatal brain of case group. a, b and c respectively represent T1WI, T2WI and DWI sequence, figure d, e respectively represent APT and MT images. Row 1: Female, newborn, 38 weeks. Left hemisphere emerging massive cerebral infarction. Left brain hemisphere displayed as long T1 and long T2. DWI showed hyperintensity, involving left temporal, and occipital lobes and the corpus callosum. APT-MT pseudo color, with left brain hemisphere of infarction lesions (black arrow, APT=0.48%, MTR=12.86%) showing a lower signal than the right hemisphere (APT=1.50%, MTR=18.43%). Row 2: Female, full-term infant. Left temporal new cerebral infarction. Left brain hemisphere displayed as DWI hyperintensity. APT-MT pseudo color, with left temporal of infarction lesions (black arrow, APT=0.44%, MTR=13.43%) showing a lower signal than the right hemisphere (APT=0.93%, MTR=16.76%). Row 3: Male, 36 w+5 d, right temporal infarction. Right temporal displayed as DWI hyperintensity. APT-MT pseudo color, with right temporal of infarction lesions (black arrow, APT=0.29%, MTR=10.25%) showing a lower signal than the right hemisphere (APT=0.91%, MTR=16.31%). Due to the formation of softening foci, partial proteolysis of brain tissue, water content in lesions increased, some artifacts appear in APT images in the lesions.

本研究結(jié)果顯示，對照組中早產(chǎn)兒與足月兒腦內(nèi)各部位APT/MTR值不同，這是由于在不同孕齡時期，腦內(nèi)發(fā)育的程度不同，腦內(nèi)蛋白質(zhì)濃度不同所致，而APT/MTR值技術(shù)對于蛋白質(zhì)濃度敏感，能夠探測到早產(chǎn)兒與足月兒之間的這種改變。而各部位的APT/MTR值不同，結(jié)果顯示APT/ MTR值由大到小依次為：基底節(jié)區(qū)、枕葉深部白質(zhì)、額葉深部白質(zhì)，這與髓鞘化順序從下至上，先中央后周圍，由背側(cè)向腹側(cè)相一致[25-26]，這正符合腦發(fā)育的順序。當(dāng)由于某種原因，如早產(chǎn)造成血管發(fā)育不良或腦細胞缺氧缺血時，有氧代謝過程受到障礙，能量來源轉(zhuǎn)為依靠糖無氧酵解，無氧酵解產(chǎn)生乳酸，使細胞發(fā)生酸中毒，此時酸中毒進一步導(dǎo)致糖代謝受到抑制，代謝率及ATP產(chǎn)生率下降，從而使細胞內(nèi)酸中毒惡性循環(huán)加重[27]。并且，由于無氧代謝能量不足，細胞膜無法維持正常的離子泵功能，Na+-H+、K+-H+離子交換紊亂，導(dǎo)致H+潴留在細胞內(nèi)，造成腦組織內(nèi)乳酸堆積[1，3，28]，導(dǎo)致代謝性酸中毒，病變組織的pH值較其他正常組織低，同時，缺氧也會導(dǎo)致少突膠質(zhì)細胞損傷[29-30]，會導(dǎo)致發(fā)育障礙，蛋白質(zhì)合成受到影響，也會導(dǎo)致APT/MTR值的降低。

對于缺氧缺血帶來的內(nèi)環(huán)境中酸堿度發(fā)生的改變，MRI常規(guī)序列是無法通過水的信號探測到的，而APT-MT技術(shù)正是一種通過組織內(nèi)蛋白質(zhì)濃度和酸堿度產(chǎn)生內(nèi)對比的新技術(shù)[31]。APT成像中，酰胺質(zhì)子與水的交換速率是關(guān)鍵因素[32-33]，而這種交換速率取決于蛋白質(zhì)濃度及pH值。Zhou等[10]的小鼠實驗結(jié)果顯示，交換速率對于體內(nèi)酸堿度非常敏感，pH值每改變0.5個單位，交換速率就會發(fā)生50%～70%的改變，這種敏感性使APT技術(shù)能夠應(yīng)用于新生兒腦損傷的評估。

圖4患兒1～3病灶處DWI序列分別為高信號、低信號，表明患兒1、2為近期新發(fā)梗死，患兒3為梗死慢性期或軟化灶形成期?；純?、2 APT/MTR值減低不如患兒3明顯，即DWI序列高信號的病灶中，APT/MTR值較DWI低信號病灶高，分析其主要原因可能是新發(fā)病灶處于細胞毒性水腫期[34]，腦組織蛋白質(zhì)變化不如梗死慢性期或軟化灶明顯。梗死慢性期或軟化灶內(nèi)腦組織蛋白質(zhì)水解，蛋白濃度減低，APT/MTR值進一步降低，故本研究觀察到陳舊梗死灶A(yù)PT/MTR值較新發(fā)梗死值更低。因此筆者推測，APT-MT成像能夠反映病灶損傷的時期，為梗死發(fā)生的時間提供信息。具體反映梗死急性期及慢性期的APT/MTR臨界值需要進一步研究。

同時，病例組結(jié)果可以得出，針對組織內(nèi)pH值敏感的APT技術(shù)能夠從內(nèi)環(huán)境水平向發(fā)病原因更進一步進行探測及無創(chuàng)評估腦損傷，這在將來應(yīng)用于體內(nèi)無創(chuàng)探測組織內(nèi)生化環(huán)境有很大前景。值得注意的是，APT技術(shù)是在一定條件下應(yīng)用的：在急性缺氧缺血時[35]，假定酰胺質(zhì)子濃度基本不變，HI導(dǎo)致的腦組織酸中毒是APT值變化的主要原因。同時，小范圍的溫度波動對于交換速率的影響是忽略不計的。APT技術(shù)在臨床應(yīng)用之前，需要解決的問題有很多[35-37]，如直接水飽和效應(yīng)、磁化傳遞及提高信噪比，如何提供更好的圖像，以及合適的掃描時間、偏置射頻脈沖的能量及翻轉(zhuǎn)角度等需要研究。總之，APT技術(shù)利用內(nèi)源性蛋白質(zhì)及酸堿度無創(chuàng)地成像，可以對新生兒腦損傷進行評估，對深入理解腦發(fā)育過程及理解腦損傷機制有幫助。

新生兒圍產(chǎn)期缺氧缺血存在著內(nèi)環(huán)境酸堿度的變化，APT-MT技術(shù)可以通過內(nèi)環(huán)境中蛋白質(zhì)濃度和酸堿度的變化來評估腦損傷，為深入理解新生兒腦損傷提供了新的思路。

[References]

[1] Liu Y, Jissendi-Tchofo P, Metens T. MR imaging, diffusion imaging, and proton MR spectroscopy at 3T in full-term neonates with hypoxic-ischemic encephalopathy. Chin J Magn Reson Imaging, 2011, 2(1): 13-18.

[2] Malik GK, Pandey M, Kumar R, et al. MR imaging and in vivo proton spectroscopy of the brain in neonates with hypoxic ischemic encephalopathy. Eur J Radiol, 2002, 43(1): 6-13.

[3] Khong PL, Tse C, Wong IY, et al. Diffusion-weighted imaging and proton magnetic resonance spectroscopy in perinatal hypoxicischemic encephalopathy: association with neuromotor outcome at 18 months of age. J Child Neurol, 2004, 19(11): 872-881.

[4] Wang HW, Wang XM, Guo QY. The correlation between DTI parameters and levels of AQP-4 in the early phases of cerebral edema after hypoxic-ischemic/reperfusion injury in piglets. Pediatr Radiol, 2012, 42(8): 992-999.

[5] Distefano G, Praticò AD. Actualities on molecular pathogenesis and repairing processes of cerebral damage in perinatal hypoxic-ischemic encephalopathy. Ital J Pediatr, 2010, 36: 63.

[6] Uria-Avellanal C, Robertson NJ. Na+/H+exchangers and intracellular pH in perinatal brain injury. Transl Stroke Res, 2014, 5(1): 79-98.

[7] Hamakawa H, Murashita J, Yamada N, et al. Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry Clin Neurosci, 2004, 58(1): 82-88.

[8] Casey JR, Grinstein S, Orlowski J. Sensors and regulators of intracellular pH. Nat Rev Mol Cell Biol, 2010, 11(1): 50-61.

[9] Schmidt H, Schwenzer NF, Gatidis S, et al. Systematic Evaluation of Amide Proton Chemical Exchange Saturation Transfer at 3 T: Effects of Protein Concentration, pH, and Acquisition Parameters. Invest Radiol, 2016, 51(10): 635-646.

[10] Zhou J, Payen J, Wilson DA, et al. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med, 2003, 9(8): 1085-1090.

[11] Yan K, Fu Z, Yang C, et al. Assessing amide proton transfer (APT) MRI contrast origins in 9 L gliosarcoma in the rat brain using proteomic analysis. Mol Imaging Biol, 2015, 17(4): 479-487.

[12] Zhou J, Wilson DA, Sun PZ, et al. Quantitative description of proton exchange processes between water and endogenous and exogenous agents for WEX, CEST, and APT experiments. Magn Reson Med, 2004, 51(5): 945-952.

[13] Jokivarsi KT, Grohn HI, Grohn OH, et al. Proton transfer ratio, lactate, and intracellular pH in acute cerebral ischemia. Magn Reson Med, 2007, 57(4): 647-653.

[14] Togao O, Kessinger CW, Huang G, et al. Characterization of lung cancer by amide proton transfer (APT) imaging: an in-vivo study in an orthotopic mouse model. PLoS One, 2013, 8(10): e77019.

[15] Dula Adrienne N, Arlinghaus Lori R, Dortch Richard D, et al. Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response. Magn Reson Med, 2013, 70(1): 216-224.

[16] Klomp Dennis WJ, Dula Adrienne N, Arlinghaus Lori R, et al. Amide proton transfer imaging of the human breast at 7 T: development and reproducibility. NMR Biomed, 2013, 26(10):1271-1277.

[17] Jia G, Abaza R, Williams JD. Amide proton transfer MR imaging of prostate cancer: a preliminary study. J Magn Reson Imaging, 2011, 33(3): 647-654.

[18] Gerigk L, Schmitt B, Stieltjes B. 7 Tesla imaging of cerebral radiation necrosis after arteriovenous malformations treatment using amide proton transfer (APT) imaging. J Magn Reson Imaging, 2012, 35(5): 1207-1209.

[19] Sun PZ, Zhou J, Sun W, et al. Detection of the ischemic penumbra using pH-weighted MRI. J Cereb Blood Flow Metab, 2007, 27(6): 1129-1136.

[20] Henkelman RM, Stanisz GJ, Graham SJ. Magnetization transfer in MRI: a review. NMR Biomed, 2001, 14(2): 57-64.

[21] Wen Z, Hu S, Huang F, et al. MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast. Neuroimage, 2010, 51(2): 616-622.

[22] Robertson NJ, Cowan FM, Cox IJ, et al. Brain alkaline intracellular pH after neonatal encephalopathy. Ann Neurol, 2002, 52(6): 732-742.

[23] Kucharczyk W, Macdonald PM, Stanisz GJ, et al. Relaxation and magnetization transfer of white matter lipidsat MR imaging: importance of cerebtosides and pH. Radiology, 1994, 192(2): 521-529.

[24] Zhou J. Amide proton transfer imaging of the human brain. Methods Mol Biol, 2011, 711: 227-237.

[25] Barkovich AJ, Kjos BO, Jackson DE Jr, et al. Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. Radiology, 1988, 166(1 pt 1): 173-180.

[26] Oishi K, Mori S, Donohue PK, et al. Multi-contrast human neonatal brain atlas: application to normal neonate development analysis. Neuroimage, 2011, 56(1): 8-20.

[27] Wang HW, Wang XM, Guo QY. The correlation between DTI parameters and levels of AQP-4 in the early phases of cerebral edema after hypoxic-ischemic reperfusion injury in piglets. Pediatric Radiology, 2012, 42(8): 992-999.

[28] Malik GK, Pandey M, Kumar R, et al. MR imaging and in vivo proton spectroscopy of the brain in neonates with hypoxic ischemic encephalopathy. Eur J Radiol, 2002, 43(1): 6-13.

[29] Fern R, M?ller T. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J Neurosci, 2000, 20(1): 34-42.

[30] Matute C, Alberdi E, Domercq M. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci, 2001, 24(4): 224-230.

[31] Zhou J, Lal B, Wilson DA, et al. Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med, 2003, 50(6): 1120-1126.

[32] Sun PZ, Zhou J, Huang Judy, at el. Simplified quantitative description of amide proton transfer (APT) imaging during acute ischemia. Magn Reson Med, 2007, 57(2): 405-410.

[33] Sun PZ, Wang E, Cheung JS. Imaging acute ischemic tissue acidosis with pH-sensitive endogenous amide proton transfer (APT) MRI: correction of tissue relaxation and concomitant RF irradiation effects toward mapping quantitative cerebral tissue PH. Neuroimage, 2012, 60(1): 1-6.

[34] Yilmaz U. Diffusion-weighted imaging in acute stroke. Radiologe, 2015, 5(9): 771-774.

[35] Liu D, Zhou J, Xue R, et al. Quantitative characterization of nuclear overhauser enhancement and amide proton transfer effects in the human brain at 7 tesla. Magn Reson Med, 2013, 70(4): 1070-1081

[36] Zhou J, Payen J, van Zijl PC. The interaction between magnetization transfer and blood-oxygen level-dependent effects. Magn Reson Med, 2005, 53(2): 356-366.

[37] Scheidegger R, Vinogradov E, Alsop DC. Amide proton transfer imaging with improved robustness to magnetic fi eld inhomogeneity and magnetization transfer asymmetry using saturation with frequency alternating RF irradiation. Magn Reson Med, 2011, 66(5): 1275-1285.

Evaluation of brain injury in neonates by magnetization transfer imaging combined amide proton transfer imaging: a preliminary study

ZHENG Yang, WANG Xiao-ming*
Department of Radiology, Shengjing Hospital of China Medical University, Shenyang 110004, China
*Correspondence to: Wang XM, E-mail: wangxm024@163.com

Objective:To evaluate neonatal brain injury at the internal environmental level with the application of amide proton transfer (APT) imaging and magnetization transfer (MT) imaging by measuring the APT and MTR values of the brain.Materials and Methods:A total of 38 neonatal patients who underwent MRI examination were enrolled in the study. Among them, there were 25 newborns with no abnormalities and 13 cases with brain injury who underwent conventional MRI (T1WI, T2WI, DWI) examination. After obtaining informed consent and permission of clinicians, routine MRI was followed by additional APT-MT scan. APT-MT imaging is single slice scanning, performed at the basal ganglia level in all neonates, and in the case group, with increased localization at the level of lesion, and with the contralateral relatively normal area as self-control. The APT/MTR values of bilateral frontal subcortical white matter, basal ganglia and occipital subcortical white matter were measured for all neonates, as well as the APT/MTR values of the lesion and contralateral areas. Several statistical methods were used for statistical analysis.Results:In the control group, bilateral frontal subcortical white matter, basal ganglia and occipital subcortical white matter had no signif i cant difference in APT/MTR values (P＞0.05). Between the different parts of the brain, the differences among the APT/ MTR of the frontal lobes, basal ganglia, and occipital lobes were signif i cant,P＜0.05. In addition, the APT/MTR values of the above brain regions were found to have a positive correlation with gestational age. In the case group, there were significant differences in APT values between the lesion side and contralateral area, being significantly lower in lesion side than the contralateral side (P＜0.05).Conclusions:From changes in the pH level in the neonatal brain, APT-MT imaging can help to understand neonatal brain injury.

國家自然科學(xué)基金(編號：30570541、30770632、81271631)

中國醫(yī)科大學(xué)附屬盛京醫(yī)院放射科，沈陽 110004

王曉明，E-mail：wangxm024@163. com

2016-12-19

接受日期：2017-01-10

R445.2；R737.9

A

10.12015/issn.1674-8034.2017.03.006

鄭陽, 王曉明. 磁化傳遞成像和酰胺質(zhì)子轉(zhuǎn)移成像聯(lián)合評價新生兒腦損傷的初步研究. 磁共振成像, 2017, 8(3): 189-195.

Received 19 Dec 2016, Accepted 10 Jan 2017

ACKNOWLEDGMENTSThis study was supported by National Natural Science Foundation of China (NO. 30570541, 30770632, 81271631).